期刊文献+

氨磺必利与氯氮平对首发精神分裂症患者社会功能的影响 被引量:7

Effects of amisulpride and clanzapine on social function of pa-tient with first-episode schizophrenia
下载PDF
导出
摘要 目的:探讨氨磺必利与氯氮平对首发精神分裂症患者社会功能的影响。方法将100例首发精神分裂症患者随机分为两组,每组50例,研究组口服氨磺必利治疗,对照组口服氯氮平治疗,观察12周。于治疗前后采用阳性与阴性症状量表评定精神症状,个人与社会功能量表评定社会功能。结果治疗后两组阳性与阴性症状量表总分及各因子分均较治疗前显著下降(P<0.01),同期两组评分比较差异无显著性(P>0.05);治疗后两组个人与社会功能量表总分均较治疗前显著升高(P<0.01),研究组较对照组升高更显著(P<0.05)。结论氨磺必利与氯氮平均能够改善精神分裂症患者的阳性、阴性症状,但氨磺必利改善患者的社会功能显著优于氯氮平。 Objective To explore the effects of amisulpride and clanzapine on social function of patient with first-episode schizophrenia .Methods A total of 100 patients with first-episode schizophrenia were randomly divided into two groups of 50 ones each ,research group took orally amisulpride and control group did clanzapine for 12 weeks .Efficacies were assessed with the Positive and Negative Syndrome Scale (PANSS) and social functions with the Personal and Social Performance Scale (PSP) .Results After treatment total scores and each factor scores of PANSS of both groups lowered more significantly compared with pretreatment (P〈0 .01) ,those had no significant group differences in the corresponding period (P〉0 .05);After treatment the PSP total scores of both groups heightened more significantly (P〈0 .01) ,so did those in research than control group (P〈0 .05) .Conclusion Both amisulpride and clozapine could im-prove positive and negative symptoms of schizophrenic ,but the former has an advantage in social functions over the latter .
出处 《临床心身疾病杂志》 CAS 2014年第5期35-37,共3页 Journal of Clinical Psychosomatic Diseases
关键词 精神分裂症 氨磺必利 氯氮平 社会功能 阳性与阴性症状量表 个人与社会功能量表 Schizophrenia amisulpride clanzapine social function PANSS PSP
  • 相关文献

参考文献16

二级参考文献64

  • 1黄文武,姜德国.抗精神病新药阿立哌唑[J].上海精神医学,2003,15(5):307-308. 被引量:153
  • 2童建明,杨正春.几种新型抗精神病药介绍[J].临床精神医学杂志,2005,15(3):182-182. 被引量:147
  • 3宋磊,王振英.抗精神病药物联合氟西汀治疗慢性精神分裂症阴性症状临床研究[J].临床心身疾病杂志,2007,13(3):207-208. 被引量:18
  • 4张明园.精神科评定量表手册.精神卫生评定量表[M].湖南科学技术出版社,1989.120-150.
  • 5李凌江.生活质量综合评定问卷-74[J].中国心理卫生杂志,2000,:88-92.
  • 6[2]中华医学会精神科分会.中国精神障碍分类与诊断标准.山东科技出版社,2001:118-119.
  • 7[1]Kopala LC, Fredrikson D, KP, et al. Symptoms in neurolepticnerve, first-episode schizophrenia: response to risperidone. Biol Psychiatry, 1998, 36: 296
  • 8[4]Lieberman JA, Mailman RB, Duncan G, et al. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry, 1998, 44: 1099~1117
  • 9[5]Bilder RM. Neurocognitive impairment in schizophrenia and how it affects treatment options. Can J Psychiatry, 1997, 42 : 255 ~264
  • 10[7]Azorin JM, Spiegel R, et al. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychoatry, 2001 Aug, 158(8) : 1305

共引文献304

同被引文献65

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部